News and Press Releases

Veristat Supports 12% of all FDA NME Approvals in 2018, a Record-Setting Year for FDA...

Veristat Celebrates Its Support of over 75 Global Regulatory Submissions Since Its Founding

Veristat Supports Antibe Therapeutics for Pain and Inflammation Study

Upon receiving approval from Health Canada, Antibe Therapeutics selected Veristat to immediately begin work on part one of a Phase 2B...

Veristat Strengthens Clinical Operations Capabilities - Acquires Topstone Research

Expanding Its Clinical Operations and Biometrics Teams Dedicated to Emerging, Small and Mid-Sized Biopharma

Veristat is Recognized on the Inc. 5000 List of America’s Fastest-Growing Private Companies...

 Veristat’s Continued Innovation of Its Clinical Development Strategies and Services Allow the Company to Execute High Quality Trials That...